Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories.
BREA, Calif., July 17, 2020 /PRNewswire/ -- Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories. The company's Immunoassay, Integrated Systems and Urinalysis instruments received IMV ServiceTrak's "Best System Performance" top honors; its Chemistry, Immunoassay, Integrated Systems, AST/ID (Microbiology), and Urinalysis systems were awarded "Best Service"; and the company's Urinalysis system received the "Best Customer Satisfaction Award." "Quality, reliability and service are the most important attributes affecting customer satisfaction," said Craig Overpeck, CEO of IMV. "We are excited and proud to congratulate Beckman Coulter on its nine awards including Best System Performance, Best Service and Best Customer Satisfaction. That is a truly great achievement for the organization, and they should be very proud of their efforts." ServiceTrak™ Clinical Laboratory Awards are based on interviews conducted with respondents in 2,229 clinical testing locations having 5,117 instruments. Laboratory professionals are asked to rate their level of satisfaction with the instrument manufacturers, the system performance, and the service received for their laboratory testing instruments. The Best System Performance and Best Service awards are given to manufacturers that receive the highest percentage of highly satisfied customer responses. The Best of Customer Satisfaction award is given to manufacturers that receive the highest percentage of respondents who would repurchase the system. Regarding Beckman Coulter's analyzers, some IMV survey respondents commented:
Beckman Coulter is dedicated to investing and developing innovative solutions that enable laboratories to optimize patient care. The company recently launched and received Emergency Use Authorization (EUA) for its Access SARS-CoV-2 IgG immunoassay, designed to target immunoglobulin G (IgG) antibodies against the coronavirus. It will also be seeking EUA for its IL-6 and Access SARS-CoV-2 Immunoglobulin M (IgM) assays in the near future. "We are honored to receive this very important industry recognition," said Bernie Duffy, Beckman Coulter's vice president of global service. "Our team is constantly striving to drive service excellence by delivering the tools and information laboratorians and medical professionals need to support patient care and improve healthcare outcomes." For more information on Beckman Coulter's award-winning solutions, please visit www.BeckmanCoulter.com. About Beckman Coulter © 2020 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.
SOURCE Beckman Coulter Diagnostics |
||
Company Codes: NYSE:DHR |